Introduction to Lipid Lowering Agents
Start with the big picture
The lesson introduces dyslipidemia and its relationship to atherosclerosis, then outlines lipid management goals. LDL-C is the primary treatment target; triglyceride control and HDL-C are additional considerations. Diet, exercise, weight management, and smoking cessation are presented as first-line measures, with medication considered when lipid levels remain above targets or cardiovascular risk is high. The overview compares major drug classes by mechanism and primary lipid effect, from statins and ezetimibe to agents targeting triglycerides. It also introduces adjunct options for familial or refractory cases. The broader chapter addresses statins’ role in prevention, combination therapy, adverse effects, contraindications, monitoring, interactions, and clinical outcomes.
What you'll learn
- Describe the lipid abnormalities associated with dyslipidemia.
- Identify LDL-C as the primary lipid treatment goal.
- Summarize the role of lifestyle modification in lipid management.
- Match major lipid-lowering drug classes with their primary lipid effects.
- Recognize why adjunct agents and combination therapy may be considered.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
